Search results
Results from the WOW.Com Content Network
According to the Journal Citation Reports, the journal has a 2016 impact factor of 1.160, ranking it 22nd out of 41 journals in the category "Social Issues," 25th out of 40 journals in the category, "Biomedical Social Sciences," and 69th out of 129 journals for the category, "Multidisciplinary Psychology." [3] Death Studies is indexed in: CINAHL
Commonly, ischemic heart attack and stroke are the causes that lead to death in patients with severe hypertension. It is estimated that for every 20 mm Hg systolic or 10 mm Hg diastolic increase in blood pressures above 115/75 mm Hg, the mortality rate for both ischemic heart disease, cancer and stroke doubles.
Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46] It has been proposed that a proportion of resistant hypertension may be the result of chronic high activity of the autonomic nervous system, known as "neurogenic hypertension". [47] Low adherence to treatment is an important cause of resistant ...
Hypertension is also associated with decreased peripheral venous compliance, [77] which may increase venous return, increase cardiac preload and, ultimately, cause diastolic dysfunction. For patients having hypertension, higher heart rate variability (HRV) is a risk factor for atrial fibrillation. [78]
Journal of Hypertension is a peer-reviewed medical journal published by Lippincott Williams & Wilkins that was established in 1982. It is the official journal of the International Society of Hypertension and the European Society of Hypertension. The journal is published monthly and includes primary papers, reviews, special reports, and letters.
On May 1, 2020, Mehra was the lead author of a small group who published results of an analysis [5] of data from 169 hospitals collected via a database funded by Surgisphere to assess the risk of in-hospital death among patients with cardiovascular disease infected with SARS-CoV2 in the New England Journal of Medicine.
The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. [3]
In medicine, systolic hypertension is defined as an elevated systolic blood pressure (SBP). [1] If the systolic blood pressure is elevated (>140) with a normal (<90) diastolic blood pressure (DBP), it is called isolated systolic hypertension. [2] Eighty percent of people with systolic hypertension are over the age of 65 years old. [3]